In vitro metabolism of the cyanotoxin cylindrospermopsin in HepaRG cells and liver tissue fractions - Anses - Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail Accéder directement au contenu
Article Dans Une Revue Toxicon Année : 2016

In vitro metabolism of the cyanotoxin cylindrospermopsin in HepaRG cells and liver tissue fractions

Résumé

No evidence for phase I metabolites of the cyanotoxin cylindrospermopsin (CYN) was given using HepaRG cells and different liver tissue fractions when studying metabolic conversion. Although the application of ketoconazole, a CYP3A4 inhibitor, led to a decreased cytotoxicity of CYN, no metabolites were detected applying high resolution mass spectrometry. Quantification of non-modified CYN led to recovery rates of almost 100%. Consequently, reduction of CYN toxicity in the presence of metabolism inhibiting agents must be attributed to alternative pathways.
Fichier non déposé

Dates et versions

anses-01346329 , version 1 (18-07-2016)

Identifiants

Citer

K Kittler, Dominique Hurtaud Pessel, R Maul, F Kolrep, Valérie Fessard,. In vitro metabolism of the cyanotoxin cylindrospermopsin in HepaRG cells and liver tissue fractions. Toxicon, 2016, 110, pp.47-50. ⟨10.1016/j.toxicon.2015.11.007⟩. ⟨anses-01346329⟩

Collections

ANSES
43 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More